We are live on ! Find out more
ARCK

Arbor Rapha Capital Bioholdings Corp. I Class A Common Stock

Delisted

ARCK was delisted on the 12th of January, 2023.

59 hedge funds and large institutions have $139M invested in Arbor Rapha Capital Bioholdings Corp. I Class A Common Stock in 2022 Q2 according to their latest regulatory filings, with 11 funds opening new positions, 15 increasing their positions, 6 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

175% more first-time investments, than exits

New positions opened: 11 | Existing positions closed: 4

150% more repeat investments, than reductions

Existing positions increased: 15 | Existing positions reduced: 6

13% more funds holding

Funds holding: 5259 (+7)

11% more capital invested

Capital invested by funds: $125M → $139M (+$14M)

Holders
59
Holders Change
+7
Holders Change %
+13.46%
% of All Funds
0.99%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
11
Increased
15
Reduced
6
Closed
4
Calls
$33K
Puts
Net Calls
+$33K
Net Calls Change

ARCK Hedge Fund Activity: Q2 2022 in Review

59 of the 5,937 institutional investors tracked by Wall St. Rank reported a position in Arbor Rapha Capital Bioholdings Corp. I Class A Common Stock (ARCK) for Q2 2022, worth a combined $139M — up 11% from $125M a quarter earlier.

Buyers outnumbered sellers: 11 funds opened new ARCK positions and 4 closed out — a net gain of 7 holders — while 15 added to existing stakes and 6 trimmed.

The largest buyer was Cantor Fitzgerald, adding an estimated $11.1M. The largest seller was Beryl Capital Management, exiting entirely with an estimated $11.7M sold.

  • 59 institutional investors held Arbor Rapha Capital Bioholdings Corp. I Class A Common Stock (ARCK) as of Q2 2022, up from 52 in Q1 2022.
  • Funds reported $139M of Arbor Rapha Capital Bioholdings Corp. I Class A Common Stock stock for Q2 2022, up 11% quarter-over-quarter.
  • 11 funds opened new Arbor Rapha Capital Bioholdings Corp. I Class A Common Stock positions in Q2 2022 and 4 closed out, a net change of +7 holders.
  • The largest Arbor Rapha Capital Bioholdings Corp. I Class A Common Stock buyer in Q2 2022 was Cantor Fitzgerald, an estimated $11.1M added.
  • The largest Arbor Rapha Capital Bioholdings Corp. I Class A Common Stock seller in Q2 2022 was Beryl Capital Management, an estimated $11.7M sold.

Based on aggregated 13F filings for Q2 2022.